We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $357M
1-Year Est. Return 13.97%
This Fund
S&P 500
This Quarter Est. Return
-13.1%
1 Year Est. Return
+13.97%
3 Year Est. Return
+50.79%
5 Year Est. Return
+74.78%
10 Year Est. Return
+368.42%
AUM
$5B
AUM Growth
-$909M
Cap. Flow
-$36.2M
Cap. Flow %
-0.72%
Top 10 Hldgs %
18.91%
Holding
2,646
New
66
Increased
797
Reduced
791
Closed
99

Sector Composition

Rank Sector Weight
1 Technology 16.99%
2 Financials 14.07%
3 Healthcare 13.89%
4 Consumer Discretionary 10.07%
5 Industrials 9.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FIBK icon
1351
First Interstate BancSystem
FIBK
$3.74B
$394K 0.01%
10,790
SCHL icon
1352
Scholastic
SCHL
$794M
$394K 0.01%
9,795
+392
+4% +$17K
VCRA
1353
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
$393K 0.01%
9,997
+498
+5% +$18K
YEXT icon
1354
Yext
YEXT
$599M
$392K 0.01%
26,402
CADE
1355
DELISTED
Cadence Bancorporation
CADE
$391K 0.01%
23,292
AVTA
1356
DELISTED
Avantax, Inc. Common Stock
AVTA
$391K 0.01%
14,669
OXM icon
1357
Oxford Industries
OXM
$546M
$390K 0.01%
5,495
AIR icon
1358
AAR Corp
AIR
$5.87B
$390K 0.01%
10,453
FCF icon
1359
First Commonwealth Financial
FCF
$2.2B
$390K 0.01%
32,303
+1,197
+4% +$16.4K
SRG
1360
Seritage Growth Properties
SRG
$127M
$390K 0.01%
12,069
-51
-0.4% -$1.97K
WD icon
1361
Walker & Dunlop
WD
$1.47B
$390K 0.01%
9,010
SCS
1362
DELISTED
Steelcase
SCS
$389K 0.01%
26,211
INVA icon
1363
Innoviva
INVA
$1.5B
$388K 0.01%
22,228
GES
1364
DELISTED
Guess Inc
GES
$388K 0.01%
18,670
ENTA icon
1365
Enanta Pharmaceuticals
ENTA
$389M
$388K 0.01%
5,474
ALSN icon
1366
Allison Transmission
ALSN
$10.3B
$387K 0.01%
8,824
-29
-0.3% -$1.34K
AMRX icon
1367
Amneal Pharmaceuticals
AMRX
$6.04B
$387K 0.01%
28,627
INN
1368
Summit Hotel Properties
INN
$660M
$386K 0.01%
39,668
-188
-0.5% -$2.13K
KRNY icon
1369
Kearny Financial
KRNY
$609M
$386K 0.01%
30,101
-4,215
-12% -$54.8K
SMPL icon
1370
Simply Good Foods
SMPL
$985M
$385K 0.01%
20,387
-3,496
-15% -$66K
BHVN
1371
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$385K 0.01%
10,413
PRK icon
1372
Park National Corp
PRK
$3.77B
$384K 0.01%
4,526
+172
+4% +$16K
TMX
1373
DELISTED
Terminix Global Holdings, Inc.
TMX
$384K 0.01%
10,449
-5,201
-33% -$216K
INST
1374
DELISTED
Instructure, Inc.
INST
$384K 0.01%
10,227
SPXC icon
1375
SPX Corp
SPXC
$10.8B
$384K 0.01%
13,692

Similar funds

Metropolitan Life Insurance Company (MetLife)'s Q4 2018 Portfolio in Review

As of Q4 2018, Metropolitan Life Insurance Company (MetLife) held 2,646 positions worth $5B, down 15% from $5.91B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Metropolitan Life Insurance Company (MetLife)'s Q4 2018 filing shows 66 new, 797 increased, 791 reduced and 99 closed positions. Its largest new stake was Equitrans Midstream Corporation Common Stock: 58,446 shares worth $1.17M. The largest sale was Aetna Inc, an estimated $10.8M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q4 2018 buy was Equitrans Midstream Corporation Common Stock: 58,446 shares worth $1.17M.
  • Metropolitan Life Insurance Company (MetLife) added most to State Street SPDR S&P 500 ETF Trust in Q4 2018, an estimated $61M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q4 2018 reduction was iShares Russell 1000 Growth ETF, cutting an estimated $10.4M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Aetna Inc in Q4 2018, selling an estimated $10.8M.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 19% of its $5B portfolio in Q4 2018.
  • Metropolitan Life Insurance Company (MetLife) opened 66 new positions and closed 99 in Q4 2018.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value fell 15% quarter-over-quarter to $5B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2018, filed 14 Feb 2019.